8 assets in Stomatitis

Therapeutic assets addressing Stomatitis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Methylene Blue Stomatitis	Mayo Clinic	P3	BB (64)
Datopotamab Deruxtecan Stomatitis	AstraZeneca	P4	B (61)
Dexasone Stomatitis	AstraZeneca	P4	B (60)
Folic Acid Stomatitis	Niels Fristrup	P2	CCC (53)
Losartan Stomatitis	Ain Shams University	P2	CCC (53)
Mit-001 Stomatitis	MitoImmune Therapeutics	P2	CCC (53)
Daunomycin Stomatitis	Peking University People's Hospital	N/A	D (30)
Etoposide Stomatitis	Peking University People's Hospital	N/A	D (30)